0042-4609

Vestnik dermatologii i venerologii

Rossijskoe Obschestvo Dermatovenerologov i Kosmetologov

View prefix report (10.25208)

Health Score

0 Good

Metadata coverage

Abstract
ORCID
References
License

Extended metadata coverage

Informational — signals of interoperability and funding across the corpus. Not part of the health score.

Funding

Funder
Award / grant

Affiliation & institutional identifiers

Affiliation
ROR ID

Update policy

Update policy

Your prioritized action plan

Ordered by how many DOIs each fix touches — start here, not with every error at once.

1

Attach ORCID iDs across 963 articles

ORCID iDs strengthen author disambiguation and institutional reporting.

High impact963 DOIs
2

Add abstracts to 117 articles

Abstracts are what surface your work in Google Scholar, Dimensions, and OpenAlex.

Low impact117 DOIs
3

Deposit reference lists for 104 records

Deposited references power Crossref's Cited-by links between your articles and the literature.

Low impact104 DOIs

DOIs for this ISSN

Showing the top 5 of 1242 DOIs, ordered by correction priority.

# Title Missing Priority Citations
1 Analysis of the epidemiological situation and dynamics of st… (10.25208/vdv913)
References ORCID
53.96 11
2 Cutaneous rosacea: a thorough overview of pathogenesis, clin… (10.25208/0042-4609-2016-92-2-21-31)
Abstract ORCID
38.91 5
3 Dermatovenereologic health care delivery management in the R… (10.25208/0042-4609-2019-95-4-8-23)
ORCID
38.60 34
4 Actinic keratoses - a systemic review (10.25208/0042-4609-2014-90-5-42-52)
Abstract ORCID
34.95 4
5 THE ASSESSMENT OF THE INCIDENCE OF SKIN DISORDERS IN RUSSIAN… (10.25208/0042-4609-2017-93-6-22-33)
ORCID
34.04 22
6 Netakimab — new IL-17а inhibitor: 12-week results of phase I… (10.25208/0042-4609-2019-95-2-15-28)
ORCID
34.04 22
7 Incidence of Syphilis in the Russian Federation Over the Per… (10.25208/0042-4609-2017-93-5-16-25)
ORCID
31.97 18
8 Long-term efficacy and safety of netakimab in patients with… (10.25208/0042-4609-2019-95-3-54-64)
ORCID
31.38 17
9 Fulminant acne. Modern solution of the problem (10.25208/0042-4609-2019-95-4-79-86)
ORCID
30.10 15
10 Molecular typing of T. pallidum clinical isolates and their… (10.25208/0042-4609-2019-95-6-29-36)
Abstract ORCID
30.10 3
11 Actinic keratosis: аctual view (10.25208/0042-4609-2019-95-6-5-13)
Abstract ORCID
30.10 3
12 The roots of international dermatology (10.25208/vdv1049)
References ORCID
30.10 3
13 Innovative therapy of severe forms of acne (10.25208/vdv1082)
Abstract ORCID
30.10 3
14 Up-to-date immunology methods for examination of the cerebro… (10.25208/vdv1087)
Abstract ORCID
30.10 3
15 A combined topical therapy of chronic dermatoses (10.25208/0042-4609-2015-91-3-147-152)
ORCID
29.40 14
16 Dermatovenereologic healthcare delivery in Russian Federatio… (10.25208/0042-4609-2016-92-3-12-28)
ORCID
29.40 14
17 Efficacy and Safety of BCD-085, a Novel Interleukin-17 Inhib… (10.25208/0042-4609-2017-93-5-52-63)
ORCID
29.40 14
18 Prevalence of hereditary epidermolysis bullosa in the Russia… (10.25208/0042-4609-2015-91-3-21-30)
ORCID
28.65 13
19 Immune pathogenesis of psoriasis (10.25208/0042-4609-2016-92-4-20-26)
ORCID
28.65 13
20 Psoriasis: clinical and epidemiological features and therapy… (10.25208/0042-4609-2018-94-3-67-76)
ORCID
28.65 13
21 Zinc, its biological role and use in dermatology (10.25208/vdv626)
ORCID
28.65 13
22 PASI (Psoriasis Area and Severity Index) in the evaluation o… (10.25208/0042-4609-2016-92-4-33-38)
ORCID
27.85 12
23 Psoriasis incidence and prevalence in the Russian Federation (10.25208/vdv724)
ORCID
27.85 12
24 Microbiome: a new era in normal and pathological changes ski… (10.25208/0042-4609-2016-92-3-102-109)
ORCID
26.98 11
25 Immune mechanisms of psoriasis. New strategies of biotherapy (10.25208/vdv814)
ORCID
26.98 11
26 Syphilis incidence in Russian Federation in 2004-2013 (10.25208/0042-4609-2014-90-5-24-31)
ORCID
25.00 9
27 Main successes, achievements. Paths of development (10.25208/0042-4609-2015-91-4-13-26)
ORCID
25.00 9
28 Hidradenitis Suppurativa: Modern Concepts of Pathogenesis an… (10.25208/0042-4609-2017-93-5-70-81)
ORCID
25.00 9
29 DYNAMICS OF INCIDENCE OF SEXUALLY TRANSMITTED INFECTIONS IN… (10.25208/0042-4609-2018-94-1-27-37)
ORCID
25.00 9
30 THERAPY OF SKIN VASCULAR MALFORMATIONS USING COPPER VAPOR LA… (10.25208/0042-4609-2018-94-1-67-77)
ORCID
25.00 9
31 Targeted photosensitizer delivery: A prospective approach to… (10.25208/0042-4609-2019-95-1-21-29)
ORCID
25.00 9
32 First experience of molecular typing and determining the ant… (10.25208/vdv594)
ORCID
25.00 9
33 Resources and activities of dermatovenereological medical or… (10.25208/0042-4609-2014-90-3-16-36)
ORCID
23.86 8
34 Current standards for diagnosis of syphilis: comparing the r… (10.25208/0042-4609-2015-91-2-11-22)
ORCID
23.86 8
35 ETIOPATHOGENETIC THERAPY OF INFLAMMATORY DERMATOSES (10.25208/0042-4609-2018-94-2-78-83)
ORCID
23.86 8
36 Microbial eczema: possibilities of correction at the present… (10.25208/0042-4609-2018-94-4-60-67)
ORCID
23.86 8
37 Key objectives of dermatovenerological assistance to the Rus… (10.25208/0042-4609-2018-94-5-9-25)
ORCID
23.86 8
38 Precision therapy for psoriasis patients (10.25208/0042-4609-2019-95-6-14-21)
Abstract ORCID
23.86 2
39 Current methods of primary examination to reveal syphilitic… (10.25208/vdv1077)
Abstract ORCID
23.86 2
40 Modern methods and approaches to studying the role of neurot… (10.25208/vdv726)
Abstract ORCID
23.86 2
41 Bioinformatic analysis of T. pallidum specific antigens (10.25208/vdv731)
ORCID
23.86 8
42 Integral approach to the external therapy of atopic dermatit… (10.25208/vdv801)
ORCID
23.86 8
43 Directions for the development of Vestnik Dermatologii i Ven… (10.25208/0042-4609-2015-91-1-22-23)
Abstract References ORCID
22.58 1
44 Natamycin - antimycotic of polyene macrolides class with unu… (10.25208/0042-4609-2015-91-3-161-184)
ORCID
22.58 7
45 Rosacea: prevalence, pathogenesis, particular features of cl… (10.25208/0042-4609-2015-91-3-36-45)
ORCID
22.58 7
46 Syphilis incidence rate in the Russian Federation in 2010-20… (10.25208/0042-4609-2015-91-5-15-23)
ORCID
22.58 7
47 Drug therapy of leprosy (10.25208/0042-4609-2016-92-4-12-19)
ORCID
22.58 7
48 Strategy “treat to target” for patients with psoriasis. Rele… (10.25208/0042-4609-2016-92-5-32-38)
ORCID
22.58 7
49 Psoriatic onychodystrophy: indices for assessing the severit… (10.25208/0042-4609-2019-95-1-9-14)
ORCID
22.58 7
50 Epidemiology of psoriasis among the elderly population and v… (10.25208/vdv1171-2020-96-5-07-18)
ORCID
22.58 7